Products

Fluvara.ai

AI-native

Design real UI instantly directly inside Figma

fluvara.ai Design / UI/UX Design & Prototyping

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$15/mo
Lower than 53% of peersNiche median $18/mo
Launched
14mo ago
2025-09-28 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Turn prompts into Figma prototypes in seconds with AI

    Sep 28, 2025 · 14mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-08-29

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free Plan
Free
5 AI prompts per day
Pro Plan
$15/mo
Unlimited AI prompts

Trial: None · Free tier included · 1 paid tier ($15) · Observed 2026-11-07 · Source page

Entry price $15/mo, Lower than 53% of peers; “UI/UX Design & Prototyping” median is $18/mo.View pricing benchmark

Pages & changes

Tracked since 2025-09-28

Key pages

Weekly snapshots
Home
fluvara.ai/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Fluvara.ai cost?
Free Plan: Free; Pro Plan: $15/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Fluvara.ai get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Fluvara.ai and what platforms does it support?
Fluvara.ai is catalogued under UI/UX Design & Prototyping: Design real UI instantly directly inside Figma. Supported platforms: Web.

Related products in this category

Design / UI/UX Design & Prototyping

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.